Acquisition of pneumococci specific effector and regulatory Cd4 + T cells localising within human upper respiratory-tract mucosal lymphoid tissue

PLoS Pathogens

Volumn 7, Issue 12, 2011, Pages

  Pido Lopez, Jeffrey ^a   Kwok, William W ^b   Mitchell, Timothy J ^c   Heyderman, Robert S ^d   Williams, Neil A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHILD; EFFECTOR CELL; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RESPIRATORY TRACT MUCOSA; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; T CELL DEPLETION; TH1 CELL; TH17 CELL; AGING; CLINICAL TRIAL; FEMALE; IMMUNOLOGY; MALE; MICROBIOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGING; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY MUCOSA; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84855281311     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002396     Document Type: Article

References (58)

1. No authors listed (1998) WHO meeting on maternal and neonatal pneumococcal immunization. Wkly Epidemiol Rec 1998 73: 187-188.
2. Mulholland EK, Adegbola RA, (2005) Bacterial infections-a major cause of death among children in Africa. N Eng J Med 352: 75-77.
3. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, (2004) on behalf of WHO Child Health Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 82: 891-970.
4. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, et al. (2005) A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 133: 891-898.
5. Obaro SK, Adegbola RA, Banya WA, Greenwood BM, (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348: 271-272.
6. Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, et al. (2005) Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med 2: e15.
7. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, et al. (2001) Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA 285: 1729-1735.
8. Hill PC, Akisanya A, Sankareh K, Cheung YB, Saaka M, et al. (2006) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43: 673-679.
9. Musher DM, Groover JE, Rowland JM, Watson DA, Struewing JB, et al. (1993) Antibody to capsular polysaccharides of Streptococcus pneumoniae Prevalence, persistence, and response to revaccination. Clin Infect Dis 17: 66-73.
10. Rapola S, Jäntti V, Haikala R, Syrjänen R, Carlone GM, et al. (2000) Natural Development of Antibodies to Pneumococcal Surface Protein A, Pneumococcal Surface Adhesin A, and Pneumolysin in Relation to Pneumococcal Carriage and Acute Otitis Media. J Infect Dis 182: 1146-1152.
11. Zhang Z, Clarke TB, Weiser JN, (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909.
12. Malley R, Trzcinski K, Srivastava A, Thompson C M, Anderson P W, et al. (2005) CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 102: 4848-4853.
13. Zhang Q, Bagrade L, Bernatoniene J, Clarke E, Paton JC, et al. (2007) Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. J Infect Dis 195: 1194-1202.
14. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
15. Mureithi MW, Finn A, Ota MO, Zhang Q, Davenport V, et al. (2009) T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J Infect Dis 200: 783-93.
16. Malley R, (2010) Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med 88: 135-42.
17. van Kempen MJ, Rijkers GT, Van Cauwenberge PB, (2000) The immune response in adenoids and tonsils. Int Arch Allergy Immunol 122: 8-19.
18. Austrian R, (1986) Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 18: 35-45.
19. Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, et al. (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.
20. Davenport V, Groves E, Hobbs CG, Williams NA, Heyderman RS, (2007) Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa. Cell Microbiol 9: 1050-1061.
21. Myles PR, McKeever TM, Pogson Z, Smith CJ, Hubbard RB, (2009) The incidence of pneumonia using data from a computerized general practice database. Epidemiol Infect 137: 709-716.
22. Oldenhove G, de Heusch M, Urbain-Vansanten G, Urbain J, Maliszewski C, et al. (2003) CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 198: 259-266.
23. Hori S, Carvalho TL, Demengeot J, (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32: 1282-91.
24. Zhang X, Izikson L, Liu L, Weiner HL, (2001) Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 167: 4245-4253.
25. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
26. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, et al. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789-3796.
27. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, et al. (2008) Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation. PLoS Pathogens 4: e1000112.
28. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, et al. (2005) Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-8.
29. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, et al. (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
30. Faria AM, Weiner HL, (2005) Oral tolerance. Immunol Rev 206: 232-259.
31. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Revs Immunol 10: 490-500.
32. Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, et al. (2007) A unique subset of CD4+CD25highFoxp3++ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13: 4345-4354.
33. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, et al. (2000) Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192: 303-310.
34. Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, et al. (2006) Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177: 4376-4383.
35. Belkaid Y, Blan RB, Suffi I, (2006) Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol Rev 212: 287-300.
36. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, et al. (2005) Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 174: 3408-3415.
37. Wong RM, Scotland RR, Lau RL, Wang C, Korman AJ, et al. (2007) Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. Int Immunol 19: 1223-1234.
38. Laughlin EM, Miller JD, James E, Fillos D, Ibegbu CC, et al. (2007) Antigen-Specific CD4+ T Cells Recognize Epitopes of Protective Antigen following Vaccination with an Anthrax Vaccine. Infect Immun 75: 1852-1860.
39. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, et al. (1993) Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 137: 977-988.
40. Foy HM, Conney MK, Allan I, (1979) Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. J Am Med Assoc 241: 253-258.
41. Laine C, Mwangi T, Thompson CM, Obiero J, Lipsitch M, et al. (2004) Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal Kenya. Infect Immun 72: 3331-3335.
42. Round JL, Mazmanian SK, (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107: 12204-12209.
43. Livingston M, Loach D, Wilson M, Tannock GW, Baird M, (2010) Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response to L. reuteri. Immunol Cell Biol 88: 99-102.
44. Christensen H, May M, Bowen L, Hickman M, Trotter CL, (2010) Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 10: 853-861.
45. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. The Lancet 363: 1871-1872.
46. Zhang Q, Leong SC, McNamara PS, Mubarak A, Malley R, et al. (2011) Characterisation of Regulatory T Cells in Nasal Associated Lymphoid Tissue in Children: Relationships with Pneumococcal Colonization. PLoS Pathog 7: e1002175 doi:10.1371/journal.ppat.1002175.
47. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 Control over Foxp3+ Regulatory T Cell Function. Science 322: 271-275.
48. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ, (2007) Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses. Immunity 27: 111-122.
49. Quigley M, Pereyra F, Nilsson B, Porichis F, Fonseca C, et al. (2010) Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 16: 1147-51.
50. Paust S, Lu L, McCarty N, Cantor H, (2004) Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 101: 10398-10403.
51. Iikuni N, Lourenço EV, Hahn BH, La Cava A, (2009) Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J Immunol 183: 1518-22.
52. Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO, (2009) A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci USA 106: 19256-19261.
53. Lim HW, Hillsamer P, Banham AH, Kim CH, (2005) Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells. J Immunol 175: 4180-4183.
54. Crome SQ, Clive B, Wang AY, Kang CY, Chow V, et al. (2010) Inflammatory Effects of Ex Vivo Human Th17 Cells Are Suppressed by Regulatory T Cells. J Immunol 85: 3199-3208.
55. Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, et al. (2010) Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's disease. J Immunol 184: 2261-2271.
56. Zhang Q, Bernatoniene J, Bagrade L, Pollard AJ, Mitchell TJ, et al. (2006) Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur J Immunol 36: 46-57.
57. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, et al. (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 17: 555-61.
58. Novak EJ, Liu AW, Nepom GT, Kwok WK, (1999) MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigen. J Clin Invest 104: R63-R6.